Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Dec 26, 2025, 4:00 PM EST
1.669
-0.001 (-0.05%)
After-hours: Dec 26, 2025, 7:49 PM EST
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Autolus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $8.33, which forecasts a 398.80% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $10.
Price Target: $8.33 (+398.80%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +498.80% | Dec 12, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +498.80% | Nov 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +498.80% | Oct 20, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +199.40% | Aug 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +498.80% | Jul 21, 2025 |
Financial Forecast
Revenue This Year
77.87M
from 10.12M
Increased by 669.49%
Revenue Next Year
149.15M
from 77.87M
Increased by 91.53%
EPS This Year
-0.98
from -0.86
EPS Next Year
-0.78
from -0.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 90.8M | 188.3M | ||||
| Avg | 77.9M | 149.2M | ||||
| Low | 70.0M | 107.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 797.5% | 141.8% | ||||
| Avg | 669.5% | 91.5% | ||||
| Low | 591.9% | 38.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.87 | -0.53 | ||||
| Avg | -0.98 | -0.78 | ||||
| Low | -1.04 | -1.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.